Back to Search
MELISSA MIZESKO, M.D.
M.D.
Pediatric Rheumatology Physician
NPI: 1003026139Individual
Specialties, Licenses & Credentials
Research & Publications (5)
Conditional expression of the mutant Ki-rasG12C allele results in formation of benign lung adenomas: development of a novel mouse lung tumor model.
PMID 16051643·Carcinogenesis·2005
7-preclinical
Tuberous sclerosis-associated neoplasms express activated p42/44 mitogen-activated protein (MAP) kinase, and inhibition of MAP kinase signaling results in decreased in vivo tumor growth.
PMID 12960139·Clin Cancer Res·2003
7-preclinical
Reactive oxygen-induced carcinogenesis causes hypermethylation of p16(Ink4a) and activation of MAP kinase.
PMID 11984000·Mol Med·2002
7-preclinical
Alterations at the Ink4a locus in transplacentally induced murine lung tumors.
PMID 11595130·Cancer Lett·2001
7-preclinical
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 3533 S. ALAMEDA
CORPUS CHRISTI, TX 78411 - Phone
- (361) 694-4864
Quick Facts
- NPI
- 1003026139
- Entity Type
- Individual
- Gender
- Female
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 5
Are you this provider?
Claim Your Profile